Trial intelligence / Profile preview

Bilastine vs Loratadine in Allergic Rhinitis

NCT02513290Phase 4Completed

Sponsor
Unisul
Start
Aug 2013
Primary completion
Aug 2014
Modality
Small Molecules
01

Overview

A Phase 4 trial of bilastine in allergic rhinitis (AR), sponsored by Unisul. Started Aug 2013; status: completed.

02

Drugs

bilastine
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT02513290.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02513290.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call